Compare

Actinium Pharmaceuticals, Inc. vs iBio, Inc. vs Inovio Pharmaceuticals, Inc. vs Connect Biopharma Holdings Ltd

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearActinium Pharmaceuticals, Inc.
ATNM
iBio, Inc.
IBIO
Inovio Pharmaceuticals, Inc.
INO
Connect Biopharma Holdings Ltd
CNTB
Year ended2025-12-312026-06-302025-12-312025-12-31
Revenue$90.0K$100.0K$65.3K$64.0K
Revenue growth (YoY)n/a-75.0%-70.0%-99.8%
Gross marginn/an/an/an/a
Operating marginn/mn/mn/mn/m
Net marginn/mn/mn/mn/m
Net income-$33.89M-$33.04M-$84.95M-$55.48M
EPS (Diluted)-$1.09-$0.32-$1.81-$1.00
Operating cash flow-$24.58M-$23.22M-$88.63M-$51.21M
Free cash flow-$24.68M-$23.80M-$88.92M-$51.64M
Cash & equivalents$48.00M$56.40M$44.27M$38.34M
Total assets$51.77M$99.11M$74.31M$56.08M
Total liabilities$43.94M$13.40M$50.21M$14.10M
Shareholders' equity$7.83M$85.71M$24.10M$41.98M
Return on year-end equity-432.6%-38.6%-352.5%-132.2%
Shares outstanding31.20M55.70M69.00M56.44M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearActinium Pharmaceuticals, Inc.iBio, Inc.Inovio Pharmaceuticals, Inc.Connect Biopharma Holdings Ltd
Latest$90.0K
Ended 2025-12-31
$100.0K
Ended 2026-06-30
$65.3K
Ended 2025-12-31
$64.0K
Ended 2025-12-31
1 year earliern/a$400.0K
Ended 2025-06-30
$217.8K
Ended 2024-12-31
$26.03M
Ended 2024-12-31
2 years earlier$81.0K
Ended 2023-12-31
$225.0K
Ended 2024-06-30
$832.0K
Ended 2023-12-31
$0
Ended 2023-12-31
3 years earlier$1.03M
Ended 2022-12-31
$0
Ended 2023-06-30
$10.26M
Ended 2022-12-31
n/a
4 years earlier$1.14M
Ended 2021-12-31
$1.88M
Ended 2022-06-30
$1.77M
Ended 2021-12-31
n/a